Identifying potential therapeutic targets of methicillin-resistant staphylococcus aureus through in vivo proteomic analysis

Journal of Infectious Diseases

Volumn 209, Issue 10, 2014, Pages 1533-1541

  Diep, Binh An ^a,b   Phung, Qui ^c   Date, Shailesh ^c   Arnott, David ^c   Bakalarski, Corey ^c   Xu, Min ^c   Nakamura, Gerald ^c   Swem, Danielle L ^c   Alexander, Mary Kate ^c   Le, Hoan N ^a   Mai, Thuy T ^a   Tan, Man Wah ^c   Brown, Eric J ^c   Nishiyama, Mireille ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GENENTECH INC   (United States)

Author keywords

bacterial pathogenesis; MRSA; proteomics; Staphylococcus aureus; vaccine and antibiotic development.

Indexed keywords

LIPOPROTEIN; PROTEIN MNTA; PROTEIN MNTB; PROTEIN MNTC; PROTEOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CLONE; CONTROLLED STUDY; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEOMICS;

BACTERIAL PATHOGENESIS; MRSA; PROTEOMICS; STAPHYLOCOCCUS AUREUS; VACCINE AND ANTIBIOTIC DEVELOPMENT;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; KIDNEY; LIPOPROTEINS; MEMBRANE PROTEINS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; PROTEOMICS; SERUM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; VIRULENCE;

EID: 84899520606     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit662     Document Type: Article

References (50)

1. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007; 13:1840-6.
2. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32.
3. Feng Y, Chen CJ, Su LH, et al. Evolution and pathogenesis of Staphylococcus aureus: lessons learned from genotyping and comparative genomics. FEMS Microbiol Rev 2008; 32:23-37.
4. Smeltzer MS, Lee CY, Harik N, Hart ME. Molecular basis of pathogenicity. In: Staphylococci in Human Diseases, Crossley KB, Jefferson GL, Archer GL, Fowler VG, eds. Oxford: Willey-Blackwell, 2009: 65-108.
5. Mazmanian SK, Liu G, Ton-That H, Schneewind O. Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall. Science 1999; 285:760-3.
6. Mazmanian SK, Ton-That H, Su K, Schneewind O. An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis. Proc Natl Acad Sci USA 2002; 99:2293-8.
7. Sutcliffe IC, Harrington DJ. Pattern searches for the identification of putative lipoprotein genes in Gram-positive bacterial genomes. Microbiology 2002; 148:2065-77.
8. Sutcliffe IC, Russell RRB. Lipoproteins of gram-positive bacteria. J Bacteriol 1995; 177:1123-8.
9. Cheng AG, Kim HK, Burts ML, et al. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 2009; 23:3393-404.
10. Corrigan RM, Mialovic H, Foster TJ. Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol 2009; 9:22.
11. Hashimoto M, Tawaratsumida K, Kariya H, et al. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int Immunol 2005; 18:355-62.
12. Garzoni C, Francois P, Huyghe A, et al. A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells. BMC Genomics 2007; 8:171.
13. Malachowa N, Whitney AR, Kobayashi SD, et al. Global changes in Staphylococcus aureus gene expression in human blood. PloS One 2011; 6:e18617.
14. Becker D, Selbach M, Rollenhagen C, et al. Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 2006; 440: 303-7.
15. Kruh NA, Troudt J, Izzo A, Prenni J, Dobos KM. Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. PloS One 2010; 5: e13938.
16. Windle HJ, Brown PA, Kelleher DP. Proteomics of bacterial pathogenicity: Therapeutic implications. Proteomics Clin Appl 2010; 4: 215-27.
17. Bumann D. Pathogen proteomes during infection: A basis for infection research and novel control strategies. J Proteomics 2010; 73:2267-76.
18. Etz H, Minh DB, Henics T, et al. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc Natl Acad Sci USA 2002; 99:6573-8.
19. Brady AB, Leid JG, Camper AK, Costerton JW, Shirtliff ME. Identification of Staphylococcus aureus proteins recognized by the antibodymediated immune response to a biofilm infection. Infect Immun 2006; 74:3415-26.
20. Hempel K, Herbst FA, Moche M, Hecker M, Becher D. Quantitative proteomic view on secreted, cell surface-associated, and cytoplasmic proteins of the methicillin-resistant human pathogen Staphylococcus aureus under iron-limited conditions. J Proteome Res 2010; 10:1657-66.
21. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillinresistant Staphylococcus aureus. Lancet 2006; 367:731-9.
22. O'Hara FP, Amrine-Madsen H, Mera RM, et al. Molecular characterization of Staphylococcus aureus in the United States 2004-2008 reveals the rapid expansion of USA300 among inpatients and outpatients. Microbiol Drug Resistance 2012; 18:555-61.
23. Diep BA, Palazzolo-Balance AM, Tattevin P, et al. Contribution of Panton-Valentine leukocidin in community-associated methicillinresistant Staphylococcus aureus pathogenesis. PloS One 2006; 3:e3198.
24. Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 2010; 107: 5587-92.
25. Bae T, Schneewind O. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 2006; 55:58-63.
26. Malo D, Vogan K, Vidal S, et al. Halotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 1994; 23:51-61.
27. Gorrill RH, Klyhn KM, McNell EM. The initiation of infection in the mouse kidney after intravenous injection of bacteria. J Pathol Bacteriol 1961; 91:157-72.
28. Schindler CA, Schulhardt VT. Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci USA 1964; 51:414-21.
29. Gatlin CL, Pieper R, Huang ST, et al. Proteomic profiling of cell envelope-associated proteins from Staphylococcus aureus. Proteomics 2006; 6:1530-49.
30. Ventura CL, Malachowa N, Hammer CH, et al. Identification of novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PloS One 2010; 5:e11364.
31. Skaar EP, Schneewind O. Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme. Microbes Infect 2004; 6:390-7.
32. Andrews SC, Robinson AK, Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS Microbiol Rev 2003; 27:215-37.
33. Bondarenko PV, Chelius D, Shaler TA. Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal Chem 2002; 74:4741-9.
34. Liu H, Sadygov RG, Yates JR 3rd. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004; 76:4193-201.
35. Mazmanian SK, Skaar EP, Gaspar AH, et al. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 2003; 299:906-9.
36. Heinrichs JH, Gatlin LE, Kunsch C, Choi GH, Hanson MS. Identification and characterization of SirA, an iron-regulated protein from Staphylococcus aureus. J Bacteriol 1999; 181:1436-43.
37. Horsburgh MJ, Wharton SJ, Cox AG, et al. MntR modulates expression of the PerR regulon and superoxide resistance in Staphulococcus aureus through control of manganese uptake. Mol Microbiol 2002; 44: 1269-86.
38. Coulter SN, Schwan WR, Ng EY, et al. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol Microbiol 1998; 30:393-404.
39. Stoll H, Dengjel J, Nerz C, Götz F. Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun 2005; 73:2411-23.
40. Kim HK, DeDent A, Cheng AG, et al. IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge. Vaccine 2010; 28:6382-92.
41. Adhikari RP, Novick RP. Regulatory organization of staphylococcal sae locus. Microbiology 2007; 154:949-59.
42. Vitikainen M, Lappalainen I, Seppala R, et al. Structure-function analysis of PrsA reveals roles for the parvulin-like and flanking N-and C-terminal domains in protein folding and secretion in Bacillus subtilis. J Biol Chem 2004; 279:19302-14.
43. Claverys JP. A new family of high-affinity ABC manganese and zinc permeases. Res Microbiol 2001; 152:231-43.
44. Nielsen JS, Christiansen MH, Bonde M, et al. Searching for small σBregulated genes in Staphylococcus aureus. Arch Microbiol 2011; 193:23-34.
45. Cassat JE, Skaar EP. Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity. Semin Immunopathol 2012; 34:215-35.
46. Forbes JR, Gros P. Divalent-metal transport by Nramp proteins at the interface of host-pathogen interactions. Trends Microbiol 2001; 9:397-403.
47. Kehl-Fie TE, Zhang Y, Moore JL, et al. MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect Immun 2013; 81:3395-405.
48. Zaharik ML, Cullen VL, Fung AM, et al. The Salmonella enterica serovar typhimurium divalent cation transport systems MntH and Sit ABCD are essential for virulence in an Nramp1G169 murine typhoid model. Infect Immun 2004; 72:5522-5.
49. Papp-Wallace KM, Maguire ME. Manganese transport and the role of manganese in virulence. Annu Rev Microbiol 2006; 60:187-209.
50. Anderson AS, Scully IL, Timofeyeva Y, et al. Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis. J Infect Dis 2012; 205:1688-96.